Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure: Observations From DECLARE-TIMI 58 Trial.

Autor: Furtado RHM; Academic Research Organization, Hospital Israelita Albert Einstein, Sao Paulo, Brazil (R.H.M.F.).; Instituto do Coracao (InCor), Hospital das Clinicas da Faculdade de Medicina, Universidade de Sao Paulo, Brazil (R.H.M.F., J.C.N.).; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital Heart and Harvard Medical School, Boston, MA (R.H.M.F., E.L.G., S.A.M., D.L.B., M.S.S., S.D.W.)., Raz I; Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Hebrew University of Jerusalem, The Faculty of Medicine, Israel (I.R.A.C., O.M.)., Goodrich EL; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital Heart and Harvard Medical School, Boston, MA (R.H.M.F., E.L.G., S.A.M., D.L.B., M.S.S., S.D.W.)., Murphy SA; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital Heart and Harvard Medical School, Boston, MA (R.H.M.F., E.L.G., S.A.M., D.L.B., M.S.S., S.D.W.)., Bhatt DL; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital Heart and Harvard Medical School, Boston, MA (R.H.M.F., E.L.G., S.A.M., D.L.B., M.S.S., S.D.W.)., Leiter LA; Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, ON, Canada (L.A.L.)., McGuire DK; Division of Cardiology, University of Texas Southwestern Medical Center and Parkland Health and Hospital System, Dallas (D.K.M.)., Wilding JPH; Department of Cardiovascular and Metabolic Medicine, University of Liverpool, United Kingdom (J.P.H.W.)., Aylward P; South Australian Health and Medical Research Institute, Flinders University and Medical Centre, Adelaide (P.A.)., Dalby AJ; Life Fourways Hospital, Randburg, Republic of South Africa (A.J.D.)., Dellborg M; Sahlgrenska Academy, University of Gothenburg, Sweden (M.D.)., Dimulescu D; Carol Davila University of Medicine and Pharmacy, Bucharest, Romania (D.D.)., Nicolau JC; Instituto do Coracao (InCor), Hospital das Clinicas da Faculdade de Medicina, Universidade de Sao Paulo, Brazil (R.H.M.F., J.C.N.)., Oude Ophuis AJM; Department of Cardiology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands (A.J.M.O.O.)., Cahn A; Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Hebrew University of Jerusalem, The Faculty of Medicine, Israel (I.R.A.C., O.M.)., Mosenzon O; Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Hebrew University of Jerusalem, The Faculty of Medicine, Israel (I.R.A.C., O.M.)., Gause-Nilsson I; BioPharmaceuticals R&D, AstraZeneca Gothenburg, Mölndal, Sweden (I.G.-N., A.M.L.)., Langkilde AM; BioPharmaceuticals R&D, AstraZeneca Gothenburg, Mölndal, Sweden (I.G.-N., A.M.L.)., Sabatine MS; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital Heart and Harvard Medical School, Boston, MA (R.H.M.F., E.L.G., S.A.M., D.L.B., M.S.S., S.D.W.)., Wiviott SD; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital Heart and Harvard Medical School, Boston, MA (R.H.M.F., E.L.G., S.A.M., D.L.B., M.S.S., S.D.W.).

Publikováno v: Circulation [Circulation] 2022 May 24; Vol. 145 (21), pp. 1581-1591. Date of Electronic Publication: 2022 May 05.

Rotablation of a tricky calcified lesion in a tortuous right coronary artery.

Autor: Rijk L; Department of Cardiology, Canisius-Wilhelmina Ziekenhuis, Nijmegen, The Netherlands. rijk.leon@gmail.com., Hoseyni Guyomi S; Department of Cardiology, Canisius-Wilhelmina Ziekenhuis, Nijmegen, The Netherlands., Remmen JJ; Department of Cardiology, Canisius-Wilhelmina Ziekenhuis, Nijmegen, The Netherlands., Oude Ophuis AJM; Department of Cardiology, Canisius-Wilhelmina Ziekenhuis, Nijmegen, The Netherlands.

Publikováno v: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation [Neth Heart J] 2020 May; Vol. 28 (5), pp. 297-298.